BevNet New York: the rise of cannabis beverages
Representing DOPE Drinks at BevNET Live New York — the rise of micro-dosed cannabis beverages and what the room told us about the next phase of the category.
In October 2024 I represented DOPE Drinks at BevNET Live in New York — the industry’s main long-form gathering for non-alcoholic and functional beverage brands.
By the time we landed in the room, DOPE was shipping into 42 US states with our micro-dosed format (5mg THC + 5mg CBD per can). First retail listing had just gone live at Top Ten Liquors. The “Born in Africa, Made in America” framing was finally landing — particularly with American buyers who treated the African origin as aspirational, not exotic.
A few things I left New York convinced of:
Micro-dosing won the category. The heavy-dose THC drinks segment was crowded and increasingly under-regulated. The cannabis-curious adult market — people who want the experience without committing to the heavy version — had no clear leader. We bet right.
Distribution is the moat. Every founder pitching at BevNET had a great can. The ones with shelf placement had a business. Beverage in the US is a distribution game, not a product game. That’s the unsexy truth nobody tells you on the BevNET stage.
Wellness is eating spirits. The conversations on stage were less about “will alcohol-free become a meaningful segment?” (settled question) and more about “which sub-categories are being created next?” — adaptogenic, nootropic, micro-dosed cannabis, mushroom-functional, magnesium-loaded sleep drinks. The grown-up drinking shelf is fragmenting fast.
A particular moment I remember: an investor at the booth asked why we’d launched into 42 states from day one rather than picking one and running deep. The honest answer — which I’d write differently now — is that we should have picked one. The 42-state launch is a vanity metric. The deep-channel play in Texas or California is what would have built the playbook faster. Lessons that became part of the International Launch Playbook.